SCHEMBL1663915

SCHEMBL1663915

Cc1ccc(C(=O)Nc2ccc(Nc3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3F)cc2)n1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 5/20 0.42
HPGDS O60760 1/20 0.41
MAPK8 P45983 1/20 0.40
EGFR P00533 3/20 0.38
NPC1 O15118 6/20 0.38
RAB9A P51151 6/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
MAPT P10636 4/20 0.38
MCL1 Q07820 2/20 0.38
NAMPT P43490 1/20 0.38
TP53 P04637 1/20 0.38
BRD4 O60885 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664832 0.97 PDE7A (0.41) PDE7AHPGDSMAPK8EGFRNPC1
SCHEMBL1663917 0.94 NPC1 (0.44) HPGDSMAPK8NPC1RAB9ASMN1; SMN2
SCHEMBL1664835 0.94 NPC1 (0.44) HPGDSMAPK8NPC1RAB9ASMN1; SMN2
SCHEMBL1665072 0.90 HPGDS (0.48) PDE7AHPGDSNPC1RAB9ASMN1; SMN2
SCHEMBL1665074 0.86 RAB9A (0.52) HPGDSNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL1664362 0.86 HPGDS (0.56) PDE7AHPGDSEGFRNPC1RAB9A
SCHEMBL1665170 0.85 NPC1 (0.45) PDE7AHPGDSMAPK8NPC1RAB9A
SCHEMBL1664802 0.83 HPGDS (0.55) PDE7AHPGDSEGFRNPC1RAB9A
SCHEMBL1664923 0.82 NPC1 (0.46) PDE7AHPGDSMAPK8NPC1RAB9A
SCHEMBL1664440 0.82 HPGDS (0.41) PDE7AHPGDSEGFRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed